Fig. 3: Disease monitoring using ctDNA/CTCs detection in pre- and post-treatment blood samples. | npj Breast Cancer

Fig. 3: Disease monitoring using ctDNA/CTCs detection in pre- and post-treatment blood samples.

From: Increased blood draws for ultrasensitive ctDNA and CTCs detection in early breast cancer patients

Fig. 3: Disease monitoring using ctDNA/CTCs detection in pre- and post-treatment blood samples.The alternative text for this image may have been generated using AI.

Results for detection in pre-treatment, post-NAC, post-surgery, and during follow-up for (a) patients with PCR and (b) patients not reaching PCR in the tumor tissue. NAC neoadjuvant chemotherapy, Post S post-surgery, ctDNA circulating tumor DNA, CTCs circulating tumor cells, PBMCs Peripheral blood mononuclear cells.

Back to article page